Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells

Podocalyxin (PCLP1) is a CD34-related sialomucin expressed by some normal cells and a variety of malignant tumors, including leukemia, and associated with the most aggressive cancers and poor clinical outcome. PCLP1 increases breast tumor growth, migration and invasion; however, its role in hematolo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Tamayo-Orbegozo, Estíbaliz, Amo, Laura, Riñón, Marta, Nieto, Naiara, Amutio, Elena, Maruri, Natalia, Solaun, Miren, Arrieta, Arantza, Larrucea, Susana
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725127/
https://ncbi.nlm.nih.gov/pubmed/29245936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21283
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items